Showing results (1-10 of 215) with videos related to
Sort By:
Pageof 22
Nature Reviews. Immunology|February 16, 2013
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?Inessa Schwab, Falk NimmerjahnCell Reports|October 13, 2015
Pathways Responsible for Human Autoantibody and Therapeutic Intravenous IgG Activity in Humanized MiceInessa Schwab, Anja Lux, Falk NimmerjahnSeminars in Immunopathology|March 23, 2012
The role of sialic acid as a modulator of the anti-inflammatory activity of IgGSybille Böhm, Inessa Schwab, Anja Lux, et al.Seminars in Immunopathology|April 30, 2014
Targeting B cells and autoantibodies in the therapy of autoimmune diseasesDaniela Kao, Anja Lux, Inessa Schwab, et al.European Journal of Immunology|January 27, 2012
IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1Inessa Schwab, Markus Biburger, Gerhard Krönke, et al.European Journal of Immunology|September 5, 2012
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivoInessa Schwab, Michaela Seeling, Markus Biburger, et al.Expert Review of Clinical Immunology|March 7, 2012
FcγRIIB: a modulator of cell activation and humoral toleranceBirgit Lehmann, Inessa Schwab, Sybille Böhm, et al.European Journal of Immunology|February 8, 2014
Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivoInessa Schwab, Sidonia Mihai, Michaela Seeling, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2015
Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 MiceJennifer Müller, Benjamin Lunz, Inessa Schwab, et al.Immunity|December 16, 2011
Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivoMarkus Biburger, Susanne Aschermann, Inessa Schwab, et al.Pageof 22